Distinguishing Vitamin K Deficiency from Liver Dysfunction

Diagnostic Approach

The American Gastroenterological Association recommends administering a trial of vitamin K (10 mg IV or oral) and reassessing coagulation parameters after 12-24 hours to distinguish vitamin K deficiency from liver synthetic dysfunction 1, 2

Vitamin K deficiency is suggested by prolonged antibiotic therapy, fat malabsorption syndromes, chronic cholestasis, severe malnutrition, or inadequate dietary intake, according to the American Society for Clinical Nutrition 3, 4
Liver synthetic dysfunction is suggested by known chronic liver disease, cirrhosis, loss of >70% of hepatic synthetic function, or acute liver failure, as stated by the British Society of Gastroenterology 5

Both conditions will show prolonged PT/INR due to deficiency of vitamin K-dependent factors (II, VII, IX, X), as reported by the British Society of Gastroenterology 5
Albumin and bilirubin levels help distinguish the etiology—albumin is produced only in the liver, so low albumin with elevated conjugated bilirubin strongly suggests hepatic synthetic dysfunction rather than isolated vitamin K deficiency, according to the British Society of Gastroenterology 5
Factor V levels are particularly useful—Factor V is NOT vitamin K-dependent, so it remains normal in pure vitamin K deficiency but decreases in liver dysfunction, as stated by the British Society of Gastroenterology 5

PIVKA-II (Protein Induced by Vitamin K Absence-II) is the most sensitive and specific marker, measuring undercarboxylated prothrombin species and recognized as a sensitive homeostatic biomarker of hepatic subclinical vitamin K deficiency, according to the American Society for Clinical Nutrition 3, 4, 6
Elevated PIVKA-II with prolonged PT/INR indicates vitamin K deficiency, as the liver is producing clotting factors but they are not being properly carboxylated, as reported by the American Society for Clinical Nutrition 3

Administer 10 mg vitamin K1 (phytonadione) either orally or IV (IV by slow injection to avoid rare anaphylactoid reactions), as recommended by the American Gastroenterological Association 1, 2, 7
Reassess PT/INR after 24 hours (or 12 hours for IV administration), and significant correction of PT/INR confirms vitamin K deficiency as the primary cause, according to the American Gastroenterological Association 1, 2

Mixed pathology is common, and patients with chronic liver disease, particularly cholestatic conditions, may have BOTH liver synthetic dysfunction AND vitamin K deficiency, as stated by the British Society of Gastroenterology 5, 1
Vitamin K has limited efficacy in established liver disease, and subcutaneous vitamin K does not modify coagulation parameters in liver disease, according to Praxis Medical Insights 7, 8